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254 The Journal of Thoracic and CardioObjective: We sought to analyze our experience with management of intrathoracic
anastomotic leak after esophagectomy.
Methods: All patients who had intrathoracic anastomotic leaks after esophagectomy
were reviewed. Management and factors affecting outcome were analyzed.
Results: From March 1993 through February 2003, 761 patients had esophagec-
tomy with intrathoracic anastomosis at our institution. Forty-eight (6.3%) pa-
tients had an anastomotic leak; one refused authorization to review his medical
record and was excluded from further analysis. Twenty-four (51.1%) patients
had a contained leak. Twenty-seven (57.4%) patients were managed nonopera-
tively. Twenty (42.6%) patients required surgical intervention that included
primary anastomotic repair in 14 patients, reinforcement of the anastomosis with
viable tissue in 6 patients, and esophageal diversion in 2 patients. A single
reoperation was done in 15 patients, and 5 patients had 2 reoperations. Median
hospitalization in the reoperative group was 31 days (range, 15-97 days) and 20
days (range, 10-42 days) in the nonoperative group (P  .0037). Four (8.5%)
patients died. Cause of death was sepsis in 2 patients and multiorgan failure and
myocardial infarction in 1 patient each. At follow-up (median, 8 months; range,
1-120 months), 10 (58.8%) patients in the reoperative group were eating a
normal diet and 5 (29.4%) patients required at least one dilatation compared
with 20 (76.9%) patients in the nonoperative group who were eating a normal
diet and 9 (34.6%) who required at least one dilatation. A noncontained leak had
an adverse effect on long-term survival (P  .04).
Conclusion: Intrathoracic anastomotic leak after esophagectomy is associated with
significant morbidity and mortality. Contained leaks often can be managed nonop-
eratively. When surgical management is required, esophagogastric continuity can
often be maintained in the majority of patients. Long-term functional results are
satisfactory and similar in both the reoperative and nonoperative groups. However,
a noncontained leak adversely affected long-term survival.
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TSIntrathoracic esophagogastric anastomotic leak afteresophagectomy is a significant cause of morbidityand mortality.1-2 Although many leaks can be man-aged nonoperatively, a significant number still willrequire reoperation.2,3 The optimal method of sur-gical management, however, remains controversial,
with opinions ranging from esophageal diversion4 to pri-
mary repair.5 The purpose of this study is to review our
recent experience with the management of intrathoracic
anastomotic leak after esophagectomy.
Patients and Methods
From March 1, 1993, to February 28, 2003, 761 patients under-
went esophagectomy with intrathoracic esophagogastric anasto-
mosis at the Mayo Clinic, Rochester, Minnesota. An anastomotic
leak was identified in 48 (6.3%) patients. One patient refused
authorization to review his medical records for this project and was
excluded from further analysis. In the remaining 47 patients the
leak was confirmed either by radiographic contrast examination or
at the time of reoperation. The medical records of these 47 patients
were retrospectively reviewed for age, sex, chemoradiation ther-
apy, details of the surgical procedure, pathologic findings, diag-
nosis and management of the esophageal leak, outcome, and
long-term survival. An anastomotic leak was defined as disruption
of the esophagogastric anastomosis, the gastric staple line, or both,
identified by radiographic contrast examination, operative explo-
ration, or both.6,7 An anastomotic leak was considered contained
when no communication existed with the pleural cavity and only
minimal extension into the mediastinal space occurred; otherwise,
the leak was considered noncontained. Operative mortality was
defined as any death occurring during the first 30 postoperative
days or during the same hospitalization. Outcome analysis for late
mortality began at either hospital discharge or 30 days after esoph-
agectomy, whichever occurred first. Because there were only 4
hospital deaths in the cohort, there is no assessment of risk factor
association with this outcome. Overall patient survival was esti-
mated by the method of Kaplan and Meier.8 The date of esopha-
gectomy was the starting point, and the date of death or last
follow-up was the end point. The associations of continuous vari-
ables with survival were evaluated with Cox proportional hazards
models.9 The  level was set at .05 for statistical significance. The
Mayo Clinic College of Medicine Institutional Review Board
approved this study.
Clinical Findings
There were 47 patients (42 men and 5 women) in the study. The
median age was 63 years and ranged from 27 to 81 years. Indica-
tion for esophagectomy was malignancy in 40 (85.1%) patients,
Barrett disease with high-grade dysplasia in 4 (8.5%) patients,
achalasia in 2 (4.3%) patients, and a peptic stricture in 1 (2.1%)
patient. The cancer was located at the gastroesophageal junction in
33 patients, the distal esophagus in 6 patients, and the upper
thoracic esophagus in 1 patient. The cell type was adenocarcinoma
in 37 patients and squamous cell carcinoma, leiomyosarcoma, and
melanoma in 1 patient each. The cancer was classified as stage 0
in 1 patient, stage I in 5 patients, stage IIA in 13 patients, stage IIB
in 2 patients, stage III in 15 patients, stage IVA in 3 patients, and
The Journal of Thoracistage IVB in 1 patient. Nine (19.1%) patients received neoadjuvant
chemoradiation therapy. Associated conditions were present in 32
(68.1%) patients and included coronary artery disease in 16
(34.0%) patients, chronic obstructive pulmonary disease in 8
(17.0%) patients, diabetes mellitus in 8 (17.0%) patients, alcohol-
ism in 8 (17.0%) patients, and peripheral vascular disease in 7
(14.9%) patients. Twenty-nine (61.7%) patients were chronic
smokers. Thirteen (27.7%) patients had a prior upper abdominal
surgical procedure that included an esophageal antireflux proce-
dure in 6 patients and a gastric bypass, pyloroplasty, staging
laparotomy, modified Heller myotomy, gastrostomy, chole-
dochoduodenostomy, and endoscopic mucosectomy in 1 patient
each.
The esophagectomy was performed through an Ivor Lewis
approach in 46 (97.9%) patients and a left thoracoabdominal
approach in 1 (2.1%) patient. Our surgical technique for esopha-
gectomy has been previously described.10 The stomach was mo-
bilized and was used as a conduit to reestablish gastrointestinal
continuity in all cases. The anastomosis was hand sewn in 2 layers
in 27 (57.5%) patients and in 1 layer in 19 (40.4%) patients. A
linear stapling device was used in 1 (2.1%) patient. The anasto-
mosis was reinforced with pleura in 17 patients, omentum in 6
patients, and mediastinal fat in 1 patient. A pyloromyotomy was
performed in 44 (93.6%) patients, and a pyloroplasty was per-
formed in 1 (2.1%) patient. Two (4.2%) patients had no drainage
procedure. A feeding jejunostomy was placed in 11 (23.4%) pa-
tients. Other concomitant procedures were performed in 17 pa-
tients and included lung resection in 8 patients, liver biopsy in 3
patients, cholecystectomy in 2 patients, and removal of a gastros-
tomy catheter, splenectomy, lysis of adhesions, and appendectomy
in 1 patient each. The pulmonary resections included a wedge
excision in 6 patients and a lobectomy in 2 patients. Four patients
had intraoperative radiation therapy. One patient had a positive
microscopic esophageal margin.
Results
Fifteen (31.9%) patients with esophageal leaks were asymp-
tomatic. Signs and symptoms were present in the remaining
32 (68.1%) patients and included pleural effusion in 27
patients, leukocytosis in 25 patients, shortness of breath in
19 patients, fever in 16 patients, chest pain in 8 patients,
hypotension in 6 patients, atrial dysrhythmias in 6 patients,
bilious drainage from the chest tube in 6 patients, hydro-
pneumothorax in 6 patients, vomiting in 4 patients, subcu-
taneous emphysema in 4 patients, and renal failure in 2
patients.
Forty-five (95.7%) patients underwent diagnostic evalu-
ation that included oral contrast examination in 37 (78.7%)
patients, computed tomography (CT) of the chest with oral
contrast in 23 (48.9%) patients, and both in 15 (31.9%)
patients. Nineteen (40.4%) of these patients had an initial
negative contrast examination result before a subsequent
examination demonstrated the leak, with the diagnosis be-
ing made on the basis of repeat oral contrast examination in
11 patients, CT in 4 patients, and clinical findings and
intraoperative examination in 2 patients each. The median
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nosis of the leak was 5 days (range, 0-9 days).
Overall, esophageal contrast examination demonstrated
the leak in 42 (93.3%) of the 45 patients. The leak was
limited to the mediastinum in 28 (62.2%) patients. Twenty-
four of these mediastinal leaks were localized and consid-
ered contained; the remaining 4 were diffuse and therefore
considered noncontained. The leak extended into the pleural
space in 14 (33.3%) patients and involved the right pleural
cavity in 12 patients, the left pleural cavity in 1 patient, and
both cavities in 1 patient; all were considered noncontained.
Overall, contrast examination revealed that the leak was
contained in 24 patients and noncontained in 18 patients.
The median time interval from esophagectomy to diagnosis
of the anastomotic leak was 7 days (range, 3-18 days), with
13 patients given diagnoses more than 10 days postopera-
tively. Fourteen patients had oral intake initiated, and 4
patients were discharged from the hospital before the leak
was diagnosed.
Eleven patients with esophageal leaks underwent imme-
diately reoperation, 9 because of large noncontained leaks
after contrast examination and 2 without any preoperative
imaging studies because of copious bilious drainage from
the chest tubes. The remaining 36 patients were initially
managed conservatively after diagnosis of the leak by with-
holding oral diet and instituting both supplemental nutrition
and broad-spectrum antibiotics. Contrast examinations were
repeated at 1 week, and oral intake was gradually resumed
if the leak decreased or resolved. Ten patients failed con-
servative management, and 9 underwent reoperation. Indi-
cations for reoperation were noncontained leaks in 6 pa-
tients and gastric outlet obstruction, chylothorax, and
empyema in 1 patient each. The tenth patient had a non-
contained leak that rapidly made him septic. Reoperation
was advised, but the patient and family refused permission
to proceed. This patient subsequently died of multiorgan
failure 15 days after esophagectomy.
Twenty-seven patients, including the patient who died,
TABLE 1. Group characteristics of 26 patients admitted to





Sepsis 8 (17.0) 3 (6.4)
Dysrhythmia 7 (14.9) 5 (10.6)
Renal failure 5 (10.6) 0
Myocardial infarction 1 (2.1) 0
Mechanical ventilation 16 (34.0) 2 (4.3)
Tracheostomy 5 (10.6) 0
Inotropic support 8 (17.0) 2 (4.3)
Hemodialysis 4 (8.5) 0were managed entirely nonoperatively. Fifteen patients
256 The Journal of Thoracic and Cardiovascular Surgery ● Febrwere asymptomatic. The remaining 12 patients were symp-
tomatic, and 4 had a noncontained leak. Three were con-
sidered adequately drained by the chest tubes, and the fourth
patient (described above) refused surgical therapy and died
of sepsis. At the time of hospital dismissal, 25 of these 27
patients had begun oral intake. Median time interval to oral
intake was 13 days (range, 5-29 days).
Twenty (42.6%) patients required surgical intervention,
11 immediately after diagnosis and 9 after failure of con-
servative management. Reoperations were performed at a
median of 10.5 days after esophagectomy (range, 3-31 days)
and 1 day (range, 0-26 days) after the diagnosis of anasto-
motic leak. All patients in the reoperative group had symp-
tomatic leaks. Indications for reoperation were large non-
contained leaks in 14 patients, persistent bile drainage in 3
patients, gastric outlet obstruction in 1 patient, chylothorax
in 1 patient, and empyema in 1 patient. At reoperation, the
source of leak was at the anastomosis in 14 patients and at
the gastric conduit staple line in 2 patients. These 2 leaks
were adjacent to the anastomosis. In 4 patients no leak was
identified at surgical exploration, although all had a leak
confirmed by oral contrast examination. The esophagus was
viable in all patients. The gastric conduit was viable in 18
patients, partially necrotic in 1 patient, and completely
necrotic in another patient. The leak was closed primarily
after debridement in 8 patients, and the anastomosis was
taken down and redone in 6 patients. Esophageal diversion
with gastric conduit resection and cervical esophagostomy
was performed in 2 patients, both as a result of extensive
gastric necrosis, which precluded reanastomosis. The re-
paired anastomosis was reinforced with pleura in 4 patients
and omentum and serratus anterior muscle in 1 patient each.
The anastomosis of the 4 patients without an identifiable
leak was not redone but was also reinforced with pleura.
Concomitant procedures performed included empyema
drainage with decortication in 3 patients and right upper
lobectomy, bronchus intermedius repair, and thoracic duct
ligation in 1 patient each. In 1 patient the thoracotomy
wound was left open and packed with gauze after
reoperation.
Five patients required a second reoperation at a median
of 16 days (range, 2-25 days) after the first reoperation.
Indications for the second reoperation were abdominal
eventration, empyema, chylothorax, cholecystitis, and de-
layed thoracotomy wound closure. No patient required a
second reoperation for recurrent leakage. Three of the pa-
tients undergoing reoperation died, 2 of sepsis and 1 of a
myocardial infarction. Seventeen patients were dismissed
from the hospital, and 12 had begun oral intake. The median
time interval to oral intake was 21 days (range, 11-43 days).
Overall, 26 (55.3%) of the 47 patients required admis-
sion to the intensive care unit. Group characteristics of these
26 patients are listed in Table 1. Median hospitalization for
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compared with 20 days (range, 10-42 days) for the nonop-
erative group (P  .0037).
Follow-up was complete in all 43 survivors and ranged
from 1 month to 10 years (median, 8 months). Fourteen
patients required anastomotic dilatation, 5 (29.4%) in the
reoperative group and 9 (33.3%) in the nonoperative group.
Oral intake was possible in 30 patients, 10 (58.8%) in the
reoperative group and 20 (76.9%) in the nonoperative
group. Two patients required additional operations during
follow-up. One patient who had esophageal diversion un-
derwent 2 operations, an inferior mesenteric artery endar-
terectomy 7 months after the original esophagectomy and a
successful colonic interposition 1.5 months after the endar-
terectomy. This patient, however, is currently on a waiting
list for kidney transplantation. The other patient required a
pyloroplasty for gastric outlet obstruction 6.8 years after the
original esophagectomy. Twenty-two patients are currently
alive (10 in the reoperative group and 12 in nonoperative
group). One patient who had esophageal diversion died 4.5
months after hospital discharge before intestinal continuity
was reestablished.
Overall 5-year survival was 25.7% (95% confidence
interval [CI], 8.4%-43.2%). The only factor that affected
survival was the presence of a noncontained leak. Five-year
survival in the noncontained leak group was 15.0% (95%
CI, 2.8%-80.4%) compared with 32.5% (95% CI, 15.9%-
66.5%) in the contained group (P .04, Figure 1). Sex, age,
operation versus conservative management, presence of
symptoms, sepsis, and need for inotropic support had no
significant effect on long-term survival.
Discussion
Although intrathoracic anastomotic leak occurs in less than
10% of patients,2,3,11 it is one of the most feared complica-
tions of esophageal resections because of its associated high
morbidity and mortality.1-7,12,13 In the present study esoph-
ageal leaks occurred in 6.3% of our patients. Others have
reported similar rates.6 The presentation of intrathoracic esoph-
ageal leak ranges from patients who are asymptomatic to those
with circulatory collapse and multiorgan system failure. The
severity of presentation is largely dependent on whether pleu-
ral space contamination and gastric necrosis occur.11
Some esophageal anastomotic leaks are suspected clini-
cally, but most are ultimately diagnosed by radiographic
esophageal contrast examination.14 In our study initial con-
trast swallow examination failed to document the leak in
nearly half of the patients. Repeat oral contrast swallow or
CT with oral radiographic contrast, however, was more
sensitive in leak detection. These methods detected leaks in
40% of our patients that were not previously detected by
contrast swallow examination. Others have reported similar
findings.2,3,15 Some investigators have recommended en-
The Journal of Thoracidoscopy for both diagnosis of the leak and assessment of
gastric conduit viability,3,11 although we have not routinely
used endoscopy for fear of enlarging the perforation and
spreading the infection.
The management of intrathoracic anastomotic leaks
should be individualized and guided by the severity of the
symptoms and the magnitude of the leak. Asymptomatic
patients and some symptomatic patients, especially those
with small contained leaks,14-16 often can be managed con-
servatively. In these patients supportive care should be
instituted, and the contrast examination should be repeated
in 5 to 7 days before oral intake is resumed.
Surgical intervention is indicated for symptomatic, non-
contained, intrathoracic, esophageal anastomotic leaks and
for those leaks for which conservative management has
failed. In our series 1 of 4 patients with symptomatic non-
contained leaks who were managed nonoperatively died.
Therefore, patients with noncontained leaks that are septic
should be rapidly resuscitated and immediately explored. At
exploration, the pleural cavity and mediastinum should be
widely debrided and drained.3 Additional intraoperative
management will depend on the extent of viability of the
esophagus and gastric conduit and on the overall medical
condition of the patient. Some surgeons advocate esopha-
geal diversion by resection of the gastric conduit with
cervical esophagostomy and delayed reestablishment of in-
testinal continuity.3,4 However, this approach commits the
patient to a prolonged and potentially hazardous intestinal
reconstruction.15-17 Our preference has been a selective
approach to the surgical management of patients with
esophageal leaks. Most of these patients can be managed
with a lesser surgical procedure that preserves intestinal
continuity. If the leak is identifiable and the gastric conduit
is healthy, the inflamed margins of the leak can be excised,
Figure 1. Probability of survival in 43 patients who were dis-
missed from the hospital after esophageal anastomotic leak. The
continuous line represents the group with a contained leak. The
broken line represents the group with a noncontained leak. Zero
time on the abscissa represents the date of esophagectomy.
Vertical bars on the curve represent 95% CIs.and the anastomosis can be closed. If the gastric conduit is
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reanastomosis might be possible. We believe that the repair
should then be reinforced with healthy well-vascularized
tissue, such as omentum, pleura, pericardium, or pedicled
muscle flap. Authors have recommended placement of ei-
ther a silicone stent across the repair or a T-tube across the
leak, with the T-limb acting as a chest thoracostomy drain-
age system.18 We, however, have not used either approach.
In our opinion esophagogastric resection and diversion
should be reserved for patients with necrosis of the gastric
conduit that precluded reanastomosis or for those with pro-
found sepsis and severe hemodynamic instability. Two of
our patients required esophageal diversion, and only one
survived long enough to be reconstructed.
Successful management of patients with an esophageal
anastomotic leak is often associated with the development
of an anastomotic stricture during long-term follow-up, and
many of these patients will require subsequent dilata-
tion.11,17,19,20 Long-term functional results achieved with
either reoperative or conservative management are similar,
with nearly identical rates of stricture formation requiring
dilatation and similar tolerance of oral intake.
In summary, intrathoracic anastomotic leak after esopha-
gectomy is associated with significant morbidity and mortality.
Initial radiographic contrast swallow examination fails to di-
agnosis many of these leaks. Contained leaks often can be
managed nonoperatively. When surgical management is re-
quired, esophageal diversion is not necessary in the majority of
patients, and esophagogastric continuity can often be main-
tained. Long-term functional results are satisfactory and simi-
lar in both the reoperative and nonoperative groups. However,
a noncontained leak adversely affects long-term survival.
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Discussion
Dr Richard F. Heitmiller (Reisterstown, Md). As an introduction,
I would like to acknowledge the Mayo Clinic’s high-volume
experience and long-term expertise with transthoracic approaches
to esophageal resection and reconstruction. Their results have set
the benchmark standards for these difficult operations. I also
congratulate the authors for being willing to report their compli-
cations. Despite our best efforts, anastomotic complications con-
tinue to occur, and we can all learn from your experience. Overall,
postesophagectomy safety and outcome are reported to be equiv-
alent, regardless of the esophagectomy technique used. On the
other hand, the effect of an anastomotic leak on a patient’s post-
operative course varies greatly depending on whether the anasto-
mosis is located in the neck or the chest. Even though leaks might
be an infrequent occurrence, they persist despite all our attempts to
prevent them. In this study the authors report a 6% leak rate. The
rate of leakage did not seem to be related to the specific anasto-
motic technique. The effect of an intrathoracic esophageal leak is
dramatic. In your study the mortality was 8.5% overall and 15% in
the reoperative group. The hospital stays for the operative and
nonoperative groups, respectively, were 31 and 21 days. Given
these results, has your group considered moving the anastomosis to
the neck by using either a transhiatal or, if you feel a thoracotomy
is essential, a 3-incision approach? Why even deal with this
complication? A cervical anastomotic leak is much easier to deal
with. The diagnosis of cervical leaks is easy, and treatment in-
volves bedside drainage. Because it is my practice to routinely use
an adjuvant jejunostomy tube, patients can be managed as outpa-
tients, with cervical wound dressings and enteral feedings. This
keeps the length of hospital stay short, only minimally longer than
that of a patient who has an uncomplicated outcome. In my opinion
oral contrast studies, especially those with video or cine tech-
niques, have been very accurate at diagnosing anastomotic leaks. I
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initial study, although I know this is reported to occur. Your
experience with oral contrast evaluation of the intrathoracic anas-
tomosis is different than mine in the evaluation of cervical anas-
tomosis. You report an overall successful diagnosis of anastomotic
leak by oral contrast in 93% of patients. However, 40% of your
patients had an initial negative study result, and the median time
from initial study to the diagnosis of a subsequent leak was 5 days.
It is not clear to me how an intrathoracic anastomosis anatomically
would change the sensitivity of an oral contrast study. The surgical
principles for managing free intrathoracic leaks are clearly out-
lined in your study: re-explore, assess esophagogastric viability,
debride the leak site as needed, reclose, consider secondary cov-
erage, and provide adequate chest drainage. You do not recom-
mend resection or diversion methods unless there is gastric conduit
ischemia. I would agree with this policy. Diversion of a previously
resected esophagus is difficult, and redo reconstructions are com-
plex and take time. Because most of your patients had esophageal
cancer, it is important to restore normal swallowing function
promptly.
My questions are as follows: What is your management plan
for contained leaks? When do you feed these patients? How do you
provide nutritional support? You have a long hospital stay for
these contained leaks. It seems more conservative than what I
would think necessary.
Dr Crestanello. Well, regarding the management plan for the
contained leaks, it depends on whether those patients are symp-
tomatic. Patients who are asymptomatic with a contained leak are
usually treated conservatively. Most of the time, the treatment is
successful. However, we have to recognize that given the high
failure rate in the identification of the leak by the oral contrast
examination, even though we might an initial study that shows a
contained leak, if the patient remains septic, we should persevere
and try to repeat the studies (gastrograffin or CT with contrast) to
rule out a noncontained leak. Regarding the nutritional support, a
significant proportion of these patients, approximately 60%, had
feeding jejunostomies that were placed at the same time as the
original operation. Therefore the nutritional support in those cases
was ensured through this feeding jejunostomy. For the remaining
patients, the nutrition was provided through parenteral nutrition.
Dr Heitmiller. When are contrast studies routinely performed
after esophagectomy? How is that test done? Is it a standard
barium swallow? Is it using video esophagography?
Dr Crestanello. The study that is currently performed in the
Mayo Clinic is a grastrograffin swallow at 4 to 7 days postoper-
atively. This is followed immediately by a thin barium examina-
tion if no leak is present. A video swallow is performed when
aspiration is suspected.
Dr Heitmiller. Can you comment on the difference in survival,
the long-term survival in the free leak versus the contained leak?
Is that difference related to the upfront difference in mortality, or
is there something related to that event that leads to long-term
survival differences?
Dr Crestanello. There is clearly a difference in the hospital
mortality in patients who have contained and noncontained leaks.
Perhaps there is something associated with the biology of those
patients that determined that they had a noncontained leak that
made them more inclined to have a worse survival. But we do not
The Journal of Thoracihave an explanation to completely account for that difference in
the survival. However, if you look at the survival curves, they are
pretty much parallel, and the difference in survival is mostly
associated with the initial mortality.
Dr Heitmiller. This study spanned 10 years’ time. Were there
any trends that you observed, and what are the lessons learned for
your group? Is there anything that you have learned that might
reduce the length of stay or reduce the incidence of anastomotic
leaks in the future?
Dr Crestanello. The incidence of anastomotic leak is pretty
much consistent—has been consistent throughout the years—and
the changes have been related to the performance of the anasto-
mosis. Some of the surgeons changed from doing a single-layer
anastomosis to doing a double-layer anastomosis. And regarding
the intraoperative management of these patients who have esopha-
gogastrectomies, more of the surgeons have decided to do a
feeding jejunostomy.
Dr Mark J. Krasna (Baltimore, Md). We have a very similar
experience, somewhat smaller, with intrathoracic anastomoses.
There are 2 things that we have found, and I would like to ask you
to answer each of them. Number one, we believe that patients who
have an intrathoracic anastomosis have better early postoperative
function in terms of their swallowing ability. Do you find that, and
is that the reason that the Mayo Clinic currently still does intratho-
racic anastomoses?
Dr Crestanello. Absolutely.
Dr Krasna. When both you and Dr Heitmiller were talking
about the survival curves, in a recent study that we are doing on
this exact topic that is not yet published, one of the striking
findings was that patients who had early intrathoracic leaks actu-
ally had a worse cancer-free survival, and I wonder if you have any
of those data, Juan, because I think Dr Heitmiller’s question is a
very good one. You might be affecting the patient’s overall im-
mune status, and therefore you are seeing more patients come back
with cancer, or perhaps in retrospect these patients actually had
cancer along wherever the leak occurred, and you had incomplete
resections. Have you looked at either of those questions?
Dr Crestanello. Regarding the swallowing function in patients
who had intrathoracic anastomosis versus a cervical anastomosis,
our belief is, as you say, that the swallowing function is better in
the patients who had an intrathoracic anastomosis compared with
the patients who had a cervical anastomosis. The rate of stricture
is less in the chest compared with in the neck. Regarding the
cancer-free survival in this group of patients compared with the
overall group of patients who had esophageal cancer, I cannot tell
you the results because we have not looked at that. However, if
you compare the overall survival of this group of patients with the
overall survival of all the patients who had Ivor Lewis esophage-
ctomies, it is not different.
Dr Thomas M. Egan (Chapel Hill, NC). Could you clarify for us
what you mean by patients requiring operation? It seems to me that
they require drainage if they leak, but that does not necessarily have
to be done through an operation. Was this a choice to operate on them,
or did they have to be operated on to establish good drainage?
Dr Crestanello. Well, we believe that symptomatic patients
who have a noncontained leak need to undergo operation. Percu-
taneous drainage of a collection might be an option, but because
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comment on it. The patients who had a noncontained leak who
were symptomatic and underwent operations, there is a very high
mortality, approximately 25%, 1 of 4 patients. As for the drainage,260 The Journal of Thoracic and Cardiovascular Surgery ● Febrinitially managed conservatively. As we said, “conservative” is
having drainage of the pleural cavity by chest tubes, either the
chest tubes that were placed at the operation or new chest tubes.
However, the sepsis in those patients in our experience did notthere were 4 patients who had noncontained leaks, and they were resolve, and eventually, they required surgical intervention.
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